ljc 10627 has been researched along with Ventilator-Associated Pneumonia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, Y; Hasegawa, H; Imamura, Y; Izumikawa, K; Kakeya, H; Kaku, N; Kohno, S; Migiyama, Y; Miyazaki, T; Morinaga, Y; Nagaoka, K; Nakamura, S; Yamada, K; Yanagihara, K; Yasuoka, A | 1 |
| Araki, N; Harada, Y; Hasegawa, H; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Morinaga, Y; Yamada, K; Yamamoto, Y; Yanagihara, K | 1 |
2 other study(ies) available for ljc 10627 and Ventilator-Associated Pneumonia
| Article | Year |
|---|---|
In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Bronchoalveolar Lavage Fluid; Cytokines; Drug Therapy, Combination; Inflammation; Lung; Maleates; Mice; Microbial Sensitivity Tests; Neutrophils; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Survival; Thienamycins; Treatment Outcome | 2013 |
In vivo efficacy and pharmacokinetics of biapenem in a murine model of ventilator-associated pneumonia with Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Colony Count, Microbial; Disease Models, Animal; Histocytochemistry; Lung; Male; Meropenem; Mice; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms; Statistics, Nonparametric; Thienamycins | 2012 |